Skip to content

Clinical trials

Phase 3 Carcinoma, Ovarian Epithelial trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Ovarian Epithelial Phase: Phase 3 Country / region: France Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20052
20061
20111
20161
20171
20192
20211
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Recruiting2
Active, not recruiting1
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
European Organisation for Research and Treatment of Cancer - EORTC3
AstraZeneca2
Medical Research Council2
AGO Study Group1
AbbVie1
Amgen1
Daiichi Sankyo1
Hospices Civils de Lyon1
ImmunoGen, Inc.1
Merck Sharp & Dohme LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Ovarian Epithelial15
Ovarian Neoplasms11
Fallopian Tube Neoplasms10
Neoplasms2
Recurrence2
Blast Crisis1
Breast Neoplasms1
Brenner Tumor1
Burkitt Lymphoma1
Carcinoma, Embryonal1

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.